Lichen Planus, Oral
Conditions
Interventions
This is a four-arm, single-blind, randomized controlled clinical trial. OLP control group: 15 patients with symptomatic oral lichen planus and treatment-naïve will apply clobetasol propionate 0.05% de
Sponsors
Faculdade de Odontologia de Piracicaba da Universidade Estadual de Campinas
Faculdade de Odontologia de Piracicaba da Universidade Estadual de Campinas
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: volunteers; diagnosed with oral lichen planus or burning mouth syndrome; treatment-naive; both genders; minimum age of 18 years
Exclusion criteria
Exclusion criteria: patients with oral lichen planus diagnosed with gastrointestinal ulcer; decompensated systemic arterial hypertension and/or decompensated diabetes mellitus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a reduction in pain, verified by the Visual Numerical Scale (VNS) of pain. Data will be collected at baseline, on the last day of treatment and 15, 30, 60 and 90 days after the last treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the improvement in quality of life, using the short version of the chronic diseases of the oral mucosa questionnaire (COMDQ-15), and to verify alterations in the patients' psycho-emotional factors, according to the anxiety and depression scale (HADS). Data will be collected at baseline, on the last day of treatment and 15, 30, 60 and 90 days after the last treatment. | — |
Countries
Brazil
Contacts
Public ContactThaís Esteves Pereira
Faculdade de Odontologia de Piracicaba da Universidade Estadual de Campinas
Outcome results
None listed